The catenins are involved in numerous cell to cell interactions. This patent covers ways of inhibiting alpha and beta catenin interactions using a chemical composition. Specifically, the patent has 3 independent claims. The first is for modulating the interaction between alpha and beta catenin with specific peptides and antibodies. The second is for a pharmaceutical composition. The third claim is for a method of modulating cell adhesion.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.